NDC 10544-516
Ranitidine 150 mg tablet
On the label: Blenheim Pharmacal, Inc.. It's repackaged: Blenheim Pharmacal, Inc. rebottles it from Amneal Pharmaceuticals's NDC 53746-253.
Where the pills inside were made
This label doesn't name the factory that makes the drug (it lists 1 site that packages it). Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Amneal Pharmaceuticals names for other drugs.
Repackaging site
- Blenheim Pharmacal, Inc., North Blenheim, New York, United States · repackages it
Recalls
- Nov 22, 2019 · Class II · Amneal Pharmaceuticals, Inc.
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Lots: HB03718A 3/2020 HB03818A 3/2020 HB03918A 3/2020 HB04018A 3/2020 HC01618A 3/2020 HC14618A 5/2020 HC14718A 5/2020 HC14818A 5/2020 HC14918A 5/2020 HC15018A 5/2020 HK02318A 9/2020 HK02418A 9/2020 HK02518A 9/2020 HK02618A 9/2020 HD03119A 3/2021 HD03219A 3/2021 HE03119A 4/2021 HE03219A 4… - Nov 22, 2019 · Class II · Amneal Pharmaceuticals, Inc.
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Lots: HB04118A 2/2020 HB04218A 2/2020 HB04318A 2/2020 HB04418A 2/2020 HF13518A 6/2020 HF13618A 6/2020 HF13718A 6/2020 HF13818A 6/2020 HK02818A 9/2020 HK02918A 9/2020 HK03018A 9/2020 HK03118A 9/2020 HL08418A 11/2020 HL08518A 11/2020 HL08618A 11/2020 HL08718A 11/2020 HB01419A 1/2021 HB0561…
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ranitidine: every company that makes it
- Form
- tablet
- Strength
- 150 mg
- Approval
- ANDA ANDA077824
- On the market since
- Oct 21, 2010
- Package NDCs
10544-516-20- Official label
- DailyMed (National Library of Medicine), updated Mar 23, 2015
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?